DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
61.57
-1.13 (-1.80%)
At close: Apr 24, 2026, 4:00 PM EDT
61.60
+0.03 (0.05%)
After-hours: Apr 24, 2026, 7:51 PM EDT
DexCom Employees
DexCom had 11,100 employees as of December 31, 2025. The number of employees increased by 800 or 7.77% compared to the previous year.
Employees
11,100
Change (1Y)
800
Growth (1Y)
7.77%
Revenue / Employee
$420,000
Profits / Employee
$75,342
Market Cap
23.76B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11,100 | 800 | 7.77% |
| Dec 31, 2024 | 10,300 | 700 | 7.29% |
| Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 600 | 9.38% |
| Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
| Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
| Dec 31, 2018 | 3,900 | 910 | 30.43% |
| Dec 31, 2017 | 2,990 | 690 | 30.00% |
| Dec 31, 2016 | 2,300 | 791 | 52.42% |
| Dec 31, 2015 | 1,509 | 448 | 42.22% |
| Dec 31, 2014 | 1,061 | 296 | 38.69% |
| Dec 31, 2013 | 765 | 67 | 9.60% |
| Dec 31, 2012 | 698 | 78 | 12.58% |
| Dec 31, 2011 | 620 | 100 | 19.23% |
| Dec 31, 2010 | 520 | 135 | 35.06% |
| Dec 31, 2009 | 385 | 81 | 26.64% |
| Dec 31, 2008 | 304 | 52 | 20.63% |
| Dec 31, 2007 | 252 | -8 | -3.08% |
| Dec 31, 2006 | 260 | 105 | 67.74% |
| Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| Edwards Lifesciences | 16,000 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
DXCM News
- 16 days ago - Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 23 days ago - Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time - Business Wire
- 6 weeks ago - Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 - Business Wire
- 7 weeks ago - DexCom Transcript: 47th Annual Raymond James Institutional Investor Conference - Transcripts
- 2 months ago - Dexcom Appoints Rick Osterloh to Board of Directors - Business Wire
- 2 months ago - HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 2 months ago - Dexcom Announces Upcoming Conference Presentation - Business Wire
- 2 months ago - DexCom Reports Better-Than-Expected Q4 Results: Details - Benzinga